loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 201739 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 KALEO INC (3)

filter

01 SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS (3)

filter

01 RX (3)

filter

01 AUVI-Q (3)

filter

01 Yes (3)

URL Supplier Web Content
SOLUTION; INTRAMUS...
EQ 0.1MG/DELIVERY
2017-11-17
201739
AUVI-Q
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION; INTRAMUS...
EQ 0.3MG/DELIVERY
2012-08-10
201739
AUVI-Q
RX
Yes
BX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
SOLUTION; INTRAMUS...
EQ 0.15MG/DELIVERY
2012-08-10
201739
AUVI-Q
RX
Yes
BX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 201739

Looking for FDA Orange Book APPLICATION 201739 3

19

KALEO INC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is EPINEPHRINE, with a corresponding application number 201739.

Regulatory Information RX

With a dosage strength EQ 0.1MG/DELIVERY

Dosage Form Route SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS

Reference Listed Drug Yes

Approved since 2017-11-17

18

KALEO INC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is EPINEPHRINE, with a corresponding application number 201739.

Regulatory Information RX

With a dosage strength EQ 0.3MG/DELIVERY

Dosage Form Route SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS

Reference Listed Drug Yes

Approved since 2012-08-10

Therapeutic Equivalence (TE) Code BX

17

KALEO INC, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is EPINEPHRINE, with a corresponding application number 201739.

Regulatory Information RX

With a dosage strength EQ 0.15MG/DELIVERY

Dosage Form Route SOLUTION; INTRAMUSCULAR, SUBCUTANEOUS

Reference Listed Drug Yes

Approved since 2012-08-10

Therapeutic Equivalence (TE) Code BX

Post Enquiry
POST ENQUIRY